Company
Mosaic Therapeutics
- Business model
- B2B
Record updated 28 September 2026
About
Mosaic is an oncology therapeutics company with a highly specialised drug discovery platform, focused on discovering, developing targeted drug combinations in novel biomarker-defined settings, where substantial unmet need remains. Syncona led a £22.5 million Series A financing of the company in 2022, committing £16.5 million alongside Cambridge Innovation Capital.